马应龙,600993,收入构成,报告日期,2019-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 医院诊疗分部,8179,-- ,-- ,--,--% 医药流通分部,48194,-- ,-- ,--,--% 未分配金额,3,-- ,-- ,--,--% 医药工业分部,71150,-- ,-- ,--,--% 马应龙,600993,收入构成,报告日期,2018-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 医院诊疗,20241,17772,2470,12.2%,2.49% 治痔类产品,81597,20214,61383,75.23%,61.94% 其他(补充),1573,142,1431,90.96%,1.44% 医药流通,78716,71646,7071,8.98%,7.13% 内部抵销,-8660,-8484,-176,2.03%,-0.18% 其他产品,46283,19357,26926,58.18%,27.17% 马应龙,600993,收入构成,报告日期,2018-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 医药工业分部,58918,-- ,-- ,--,--% 医院诊疗分部,10634,-- ,-- ,--,--% 医药商业分部,37677,-- ,-- ,--,--% 马应龙,600993,收入构成,报告日期,2017-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 治痔类产品,75787,17284,58503,77.19%,66.76% 其他产品,36735,16555,20180,54.93%,23.03% 医院诊疗,17201,14977,2224,12.93%,2.54% 其他(补充),1404,202,1202,85.6%,1.37% 医药流通,51856,46256,5600,10.8%,6.39% 内部抵销,-7924,-7849,-75,0.95%,-0.09% 马应龙,600993,收入构成,报告日期,2017-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 医院诊疗分部,7952,-- ,-- ,--,--% 医药商业分部,18206,-- ,-- ,--,--% 医药工业分部,52054,-- ,-- ,--,--% 马应龙,600993,收入构成,报告日期,2016-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),2491,133,2358,94.67%,3.09% 内部抵销,-2857,-2826,-31,1.08%,-0.04% 医院诊疗,13927,12288,1640,11.78%,2.15% 医药流通,101705,95383,6322,6.22%,8.28% 其他产品,31228,13811,17418,55.78%,22.82% 治痔类产品,63786,15156,48630,76.24%,63.7% 马应龙,600993,收入构成,报告日期,2016-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),1167,66,1101,94.36%,3.04% 内部抵销,-2523,-2523,0,0%,0% 医院诊疗,6791,5542,1249,18.39%,3.45% 医药流通,44415,41551,2864,6.45%,7.92% 其他产品,10931,5281,5650,51.69%,15.62% 肛肠治痔类产品,34054,8740,25314,74.33%,69.97% 马应龙,600993,收入构成,报告日期,2015-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),1589,105,1484,93.39%,2.11% 内部抵销,-2684,-2684,0,0%,0% 医院诊疗,11643,8536,3108,26.69%,4.41% 医药流通,83189,77487,5702,6.85%,8.1% 其他产品,26373,11392,14981,56.81%,21.28% 肛肠治痔类产品,58259,13122,45137,77.48%,64.11% 马应龙,600993,收入构成,报告日期,2015-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 内部抵销,-2891,-2891,0,0%,0% 其他产品,8887,3927,4960,55.81%,14.12% 其他(补充),868,77,792,91.18%,2.25% 医药流通,39009,36259,2750,7.05%,7.83% 医院诊疗,5272,3705,1566,29.71%,4.46% 治痔类产品,32709,7650,25059,76.61%,71.34% 马应龙,600993,收入构成,报告日期,2014-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 医院诊疗,7571,5384,2187,28.89%,3.23% 治痔类产品,53814,12326,41488,77.09%,61.24% 其他(补充),396,40,356,89.83%,0.53% 医药商业,76513,69823,6690,8.74%,9.87% 内部抵销,-3341,-3269,-72,2.15%,-0.11% 其他产品,27127,10026,17101,63.04%,25.24% 马应龙,600993,收入构成,报告日期,2014-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),801,23,777,97.07%,2.17% 内部抵销,-1456,-1456,0,0%,0% 医院诊疗,3399,2110,1289,37.92%,3.6% 零售、批发业务,34999,32225,2774,7.93%,7.75% 其他产品,9751,3888,5863,60.12%,16.38% 肛肠类产品,32758,7664,25094,76.6%,70.1% 马应龙,600993,收入构成,报告日期,2013-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),1341,95,1246,92.9%,1.82% 内部抵销,-2248,-2140,-108,4.8%,-0.16% 医院诊疗,6598,4000,2598,39.37%,3.79% 零售、批发业务,74797,67660,7137,9.54%,10.41% 其他产品,25761,10335,15426,59.88%,22.5% 治痔类产品,53979,11702,42278,78.32%,61.65% 马应龙,600993,收入构成,报告日期,2013-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 医院诊疗,3285,2065,1220,37.15%,3.51% 零售、批发业务,35516,32034,3481,9.8%,10.01% 其他(补充),732,31,701,95.72%,2.02% 内部抵消,-1543,-1543,0,0%,0% 其他产品,8904,3852,5052,56.74%,14.53% 治痔类产品,31315,6995,24320,77.66%,69.94% 马应龙,600993,收入构成,报告日期,2012-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),1511,454,1057,69.95%,1.65% 内部抵消,-3826,-3842,15,-0.4%,0.02% 医院诊疗,5796,3697,2099,36.21%,3.27% 医药流通,75524,67688,7836,10.38%,12.22% 其他产品,24255,10644,13611,56.11%,21.23% 治痔类产品,50943,11441,39503,77.54%,61.61% 马应龙,600993,收入构成,报告日期,2012-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 医院诊疗,2804,1740,1064,37.94%,3.28% 其他类,8169,3850,4320,52.88%,13.31% 药品零售批发,37641,33468,4173,11.09%,12.86% 治痔类,28699,6553,22146,77.17%,68.23% 其他(补充),768,12,756,98.43%,2.33% 马应龙,600993,收入构成,报告日期,2011-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),1453,57,1396,96.06%,2.5% 医院诊疗收入,3374,1717,1656,49.1%,2.97% 零售、批发业务收入,77062,69018,8045,10.44%,14.42% 其他产品,15003,5417,9586,63.9%,17.18% 治痔类产品,44663,9546,35116,78.63%,62.93% 马应龙,600993,收入构成,报告日期,2011-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),633,18,615,97.13%,2.23% 医院诊疗收入,1244,556,688,55.32%,2.5% 零售、批发业务收入,34846,30733,4113,11.8%,14.93% 其他产品,6559,3947,2612,39.83%,9.49% 治痔类产品,24734,5223,19511,78.88%,70.85% 马应龙,600993,收入构成,报告日期,2010-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 医院诊疗,1762,967,795,45.1%,1.84% 药品零售批发,67796,59967,7829,11.55%,18.13% 其他产品,13527,6413,7114,52.59%,16.48% 治痔类产品,33453,6020,27433,82.01%,63.55% 马应龙,600993,收入构成,报告日期,2010-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 医疗,962,374,588,61.14%,2.42% 药品零售批发,29532,25219,4313,14.6%,17.79% 其他类,4973,2482,2491,50.1%,10.27% 治痔类,21244,4387,16856,79.35%,69.51% 马应龙,600993,收入构成,报告日期,2009-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 医院诊疗收入,247,248,-1,-0.21%,-0% 零售、批发业务收入,60778,51643,9135,15.03%,24.15% 其他产品,7594,4157,3437,45.26%,9.09% 治痔类产品,32609,7359,25250,77.43%,66.76% 马应龙,600993,收入构成,报告日期,2009-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 药品零售批发,30805,26762,4043,13.12%,21.9% 其他类,4530,2546,1983,43.78%,10.74% 治痔类,16274,3843,12431,76.39%,67.35% 马应龙,600993,收入构成,报告日期,2008-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 抵销,-8447,-8447,0,0%,0% 零售、批发业务收入,53193,46939,6254,11.76%,20.36% 其他产品,7530,4038,3492,46.37%,11.37% 治痔类产品,27909,6934,20974,75.15%,68.28% 马应龙,600993,收入构成,报告日期,2008-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,21397,17152,4246,19.84%,29.13% 治痔类,13361,3031,10330,77.32%,70.87% 马应龙,600993,收入构成,报告日期,2007-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 药品零售批发,23538,19160,4378,18.6%,18.61% 其他类,12052,7514,4537,37.65%,19.29% 治痔类,19124,4517,14606,76.38%,62.1% 马应龙,600993,收入构成,报告日期,2007-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,16649,12657,3992,23.98%,34.75% 治痔类,9789,2294,7494,76.56%,65.25% 马应龙,600993,收入构成,报告日期,2006-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他类,33467,23157,10310,30.81%,39.96% 治痔类,20093,4601,15492,77.1%,60.04% 马应龙,600993,收入构成,报告日期,2006-09-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,8947,6478,2469,27.6%,44.56% 治痔类,3991,918,3073,76.99%,55.44% 马应龙,600993,收入构成,报告日期,2006-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,15961,10707,5253,32.91%,41.91% 治痔类,9521,2240,7281,76.47%,58.09% 马应龙,600993,收入构成,报告日期,2006-03-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,7929,5220,2709,34.17%,54.06% 治痔系列,3027,725,2302,76.05%,45.94% 马应龙,600993,收入构成,报告日期,2005-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他类,22280,13226,9054,40.64%,37.93% 治痔类,18899,4085,14814,78.39%,62.07% 马应龙,600993,收入构成,报告日期,2005-09-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,5549,3516,2033,36.64%,44.28% 治痔类,3316,758,2558,77.14%,55.72% 马应龙,600993,收入构成,报告日期,2005-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,10450,6043,4407,42.17%,39.06% 治痔类,8638,1762,6876,79.6%,60.94% 马应龙,600993,收入构成,报告日期,2005-03-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其它产品,2204,976,1228,55.73%,33.08% 治痔系列,3069,584,2485,80.96%,66.92% 马应龙,600993,收入构成,报告日期,2004-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 内部抵消,-491,0,-491,100%,-1.76% 其他产品,10479,0,10479,100%,37.57% 治痔类产品,17903,0,17903,100%,64.19% 马应龙,600993,收入构成,报告日期,2004-09-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 马应龙麝香痔疮栓,570,74,497,87.05%,22.05% 马应龙麝香痔疮膏,2431,676,1755,72.18%,77.95% 马应龙,600993,收入构成,报告日期,2004-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 麝香痔疮栓,2588,327,2261,87.36%,35.47% 麝香痔疮膏,5664,1550,4114,72.63%,64.53% 马应龙,600993,收入构成,报告日期,2003-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 零售、批发收入,6424,5755,669,10.42%,3.92% 达芬霖,886,263,624,70.35%,3.65% 达芬拉露,220,66,154,70.01%,0.9% 斯普林,2126,240,1886,88.72%,11.05% 肝乐宁,1231,197,1034,83.97%,6.06% 复方甘草合剂,2793,1585,1207,43.24%,7.08% 麝香痔疮栓,3952,499,3453,87.38%,20.24% 麝香痔疮膏,11057,3019,8038,72.7%,47.1% 马应龙,600993,收入构成,报告日期,2002-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 零售、批发收入,3418,2805,613,17.92%,4.25% 达芬霖,657,224,433,65.85%,3% 达芬拉露,494,115,378,76.63%,2.62% 斯普林,1130,115,1014,89.78%,7.03% 肝乐宁,1434,132,1302,90.77%,9.03% 复方甘草合剂,2899,1511,1388,47.87%,9.63% 麝香痔疮栓,2242,317,1924,85.84%,13.35% 麝香痔疮膏,10260,2895,7366,71.79%,51.09% 马应龙,600993,收入构成,报告日期,2001-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,2015,-- ,-- ,--,0% 零售、批发,1936,-- ,-- ,--,0% 达芬霖,355,-- ,-- ,--,0% 达芬拉露,534,-- ,-- ,--,0% 斯普林注射液,1182,0,1182,100%,7.55% 麝香痔疮栓,1455,0,1455,100%,9.3% 肝乐宁注射液,1699,0,1699,100%,10.85% 复方甘草合剂,2458,0,2458,100%,15.71% 麝香痔疮膏,8857,0,8857,100%,56.59%